Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (9706)	6/16/1998 10:17:00 AM
From: VLAD	Read Replies (1) \| Respond to of 23519

good comment from the PFE thread: SI Inbox \| Folders Bookmarks \| People Hot \| New Subjects Options \| Profile Talk : Biotechnology : PFE (Pfizer) How high will it go? \| Previous \| Next \| Respond \| Earnings \| Silicon Investor Home Page To: James Baker (3542 ) From: James Baker Tuesday, Jun 16 1998 8:29AM ET Reply # of 3547 Highlight this portion of favorable INDEPENDENT MUSE study: ''MUSE is a good treatment option for men with diabetes and/or vascular disease especially because it has few systemic side effects,'' said Kenneth Snow, MD, Medical Director of the Joslin-Lahey Diabetes & Endocrinology Center in Peabody, MA and a lead investigator in this trial. The authors also concluded that MUSE appears to be more effective in men over the age of 50 and perhaps more effective in men with organic risk factors, as opposed to psychological factors. Approximately 80% of all cases of erectile dysfunction are believed to have a physiological origin. The investigators also noted that patient education is critical to the success of the treatment. >>>>>>>>>> Joslin is one of the premiere diabetic clinics in the world! The importance of patient education is emphasized. This is a point I have made with Urologists online who have not been getting this kind of result with MUSE. Let's give all patients the same degree of good patient care. Jim \| Previous \| Next \| Respond \| Quotes - 100-Day Chart - News - Profile - Earnings - Discussion - Biotechnology View SubjectMarks Bookmark this Subject Pfizer (NYSE: PFE) Time: 9:54AM Last Trade 108 1/8 Change + 1/8 (+0.12%) Bid Ask Volume 0412,1000 Prev.Close 108 00 Open 109 5/16 Day Range 108 1/8 - 109 5/16 Last Tick 0Down0 Avg.Volume 05,582,9000 Discussion \| People \| MetaCrawler Subject Titles Only Full-Text Messages with Links Send questions and feedback to webmistress@techstocks.com Terms of Use